Skip to main content
About us
Who We Are
Leadership Team
Board of Directors
Scientific Advisors
AI platform technologies
Pipeline
Overview
Investors
Overview
Evaxion Shares
Share Data
Share Charts
Historical Lookup
Investment Calculator
Analyst Coverage
Reports & Presentations
Quarterly Reports
Annual Reports
SEC Filings
Financial Calendar
Presentations
Corporate Governance
Governance Documents
Committees
Annual Shareholder Meeting
Resources
Investor FAQs
News & Events
Press Releases
Events
Stay in Touch
Careers
Contact
Contact us
Site Search
open mobile navigation
Press Releases
close mobile navigation
About us
Who We Are
Leadership Team
Board of Directors
Scientific Advisors
AI platform technologies
Pipeline
Overview
Investors
Overview
Evaxion Shares
Share Data
Share Charts
Historical Lookup
Investment Calculator
Analyst Coverage
Reports & Presentations
Quarterly Reports
Annual Reports
SEC Filings
Financial Calendar
Presentations
Corporate Governance
Governance Documents
Committees
Annual Shareholder Meeting
Resources
Investor FAQs
News & Events
Press Releases
Events
Stay in Touch
Careers
Contact
Contact us
Normal
Press release year list
2022
2021
2020
2019
2018
2017
2016
12/20/2019
Evaxion raises nearly $17 million in Q4
10/30/2019
Glenn S. Vraniak Joins Evaxion as CFO
04/05/2019
Evaxion announces dosing of first patient
Download
PDF format download (opens in new window)
01/09/2019
Evaxion Granted Approval for Clinical Trial Application and Investigation Medicinal Product Dossier